Healthcare stocks gain favor as State Street upgrades sector outlook on drug pipeline and earnings growth.
State Street Investment Management has upgraded its healthcare sector outlook from neutral to positive for Q3 2026, citing expected earnings growth of 19.3% in 2027, driven by biopharma innovations and stabilizing managed care trends. Despite recent ...
